{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:31:40Z","timestamp":1792859500377,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically evaluate glioma radiomics literature on differentiating between radiation-induced brain injury and tumor recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Literature was searched on PubMed and Web of Science (end date: May 7, 2024). Quality of eligible papers was assessed using METhodological RadiomICs Score (METRICS) and Radiomics Quality Score (RQS). Reliability of quality scoring tools were analyzed. Meta-analysis, meta-regression, and subgroup analysis were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-seven papers were included in the qualitative assessment. Mean average METRICS score and RQS percentage score across three readers was 57% (SD, 14%) and 16% (SD, 12%), respectively. Score-wise inter-rater agreement for METRICS ranged from poor to excellent, while RQS demonstrated moderate to excellent agreement. Item-wise agreement was moderate for both tools. Meta-analysis of 11 eligible studies yielded an estimated area under the receiver operating characteristic curve of 0.832 (95% CI, 0.757\u20130.908), with significant heterogeneity (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200991%) and no statistical publication bias (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.051). Meta-regression did not identify potential sources of heterogeneity. Subgroup analysis revealed high heterogeneity across all subgroups, with the lowest\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      at 68% in studies with proper validation and higher quality scores. Statistical publication bias was generally not significant, except in the subgroup with the lowest heterogeneity (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.044). However, most studies in both qualitative analysis (26\/27; 96%) and primary meta-analysis (10\/11; 91%) reported positive effects of radiomics, indicating high non-statistical publication bias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While a good performance was noted for radiomics, results should be interpreted cautiously due to heterogeneity, publication bias, and quality issues thoroughly examined in this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Radiomic literature on distinguishing radiation-induced brain injury from glioma recurrence lacks systematic reviews and meta-analyses that assess methodological quality using radiomics-specific tools<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>While the results are encouraging, there was substantial heterogeneity, publication bias toward positive findings, and notable concerns regarding methodological quality<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Meta-analysis results need cautious interpretation due to significant problems detected during the analysis (e.g., suboptimal quality, heterogeneity, bias), which may help explain why radiomics has not yet been translated into clinical practice<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-025-11401-x","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:19:26Z","timestamp":1739355566000},"page":"4490-4505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Radiomics for differentiating radiation-induced brain injury from recurrence in gliomas: systematic review, meta-analysis, and methodological quality evaluation using METRICS and RQS"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7307-396X","authenticated-orcid":false,"given":"Burak","family":"Kocak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4429-6996","authenticated-orcid":false,"given":"Ismail","family":"Mese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8175-4052","authenticated-orcid":false,"given":"Ece","family":"Ates Kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"11401_CR1","doi-asserted-by":"publisher","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","DOI":"10.1093\/neuonc\/noab106"},{"key":"11401_CR2","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol 24:v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro Oncol"},{"key":"11401_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"11401_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z","journal-title":"Nat Rev Clin Oncol"},{"key":"11401_CR5","doi-asserted-by":"publisher","unstructured":"Dagdelen M, Demir E, Uzel OE (2022) Radiotherapy in the treatment of low-grade gliomas. Cerrahpasa Med J. https:\/\/doi.org\/10.5152\/cjm.2022.21056","DOI":"10.5152\/cjm.2022.21056"},{"key":"11401_CR6","doi-asserted-by":"publisher","unstructured":"Carceller F, Mandeville H, Mackinnon AD, Saran F (2017) Facing pseudoprogression after radiotherapy in low grade gliomas. Transl Cancer Res. https:\/\/doi.org\/10.21037\/tcr.2017.03.46","DOI":"10.21037\/tcr.2017.03.46"},{"key":"11401_CR7","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.3390\/ijms150711832","volume":"15","author":"K Parvez","year":"2014","unstructured":"Parvez K, Parvez A, Zadeh G (2014) The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence. Int J Mol Sci 15:11832\u201311846. https:\/\/doi.org\/10.3390\/ijms150711832","journal-title":"Int J Mol Sci"},{"key":"11401_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","volume":"9","author":"D Brandsma","year":"2008","unstructured":"Brandsma D, Stalpers L, Taal W et al (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453\u2013461. https:\/\/doi.org\/10.1016\/S1470-2045(08)70125-6","journal-title":"Lancet Oncol"},{"key":"11401_CR9","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/j.wneu.2018.12.118","volume":"124","author":"M Salvati","year":"2019","unstructured":"Salvati M, Pesce A, Palmieri M et al (2019) The role and real effect of an iterative surgical approach for the management of recurrent high-grade glioma: an observational analytic cohort study. World Neurosurg 124:e480\u2013e488. https:\/\/doi.org\/10.1016\/j.wneu.2018.12.118","journal-title":"World Neurosurg"},{"key":"11401_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jon.12687","volume":"30","author":"AV Bonm","year":"2020","unstructured":"Bonm AV, Ritterbusch R, Throckmorton P, Graber JJ (2020) Clinical imaging for diagnostic challenges in the management of gliomas: a review. J Neuroimaging 30:139\u2013145. https:\/\/doi.org\/10.1111\/jon.12687","journal-title":"J Neuroimaging"},{"key":"11401_CR11","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2009.26.3541","journal-title":"J Clin Oncol"},{"key":"11401_CR12","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059","volume":"41","author":"PY Wen","year":"2023","unstructured":"Wen PY, van den Bent M, Youssef G et al (2023) RANO 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol 41:5187\u20135199. https:\/\/doi.org\/10.1200\/JCO.23.01059","journal-title":"J Clin Oncol"},{"key":"11401_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11060-023-04262-1","volume":"162","author":"EJ Smith","year":"2023","unstructured":"Smith EJ, Naik A, Shaffer A et al (2023) Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities. J Neurooncol 162:15\u201323. https:\/\/doi.org\/10.1007\/s11060-023-04262-1","journal-title":"J Neurooncol"},{"key":"11401_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2214\/AJR.11.7417","volume":"198","author":"GM Fatterpekar","year":"2012","unstructured":"Fatterpekar GM, Galheigo D, Narayana A et al (2012) Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum\u2014use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 198:19\u201326. https:\/\/doi.org\/10.2214\/AJR.11.7417","journal-title":"AJR Am J Roentgenol"},{"key":"11401_CR15","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.21037\/qims-22-32","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang Y, Wang Y et al (2022) Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression. Quant Imaging Med Surg 12:4805\u20134822. https:\/\/doi.org\/10.21037\/qims-22-32","journal-title":"Quant Imaging Med Surg"},{"key":"11401_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.721821","volume":"11","author":"M Celli","year":"2021","unstructured":"Celli M, Caroli P, Amadori E et al (2021) Diagnostic and prognostic potential of 18F-FET PET in the differential diagnosis of glioma recurrence and treatment-induced changes after chemoradiation therapy. Front Oncol 11:721821. https:\/\/doi.org\/10.3389\/fonc.2021.721821","journal-title":"Front Oncol"},{"key":"11401_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejrad.2011.01.080","volume":"81","author":"A Santra","year":"2012","unstructured":"Santra A, Kumar R, Sharma P et al (2012) F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI. Eur J Radiol 81:508\u2013513. https:\/\/doi.org\/10.1016\/j.ejrad.2011.01.080","journal-title":"Eur J Radiol"},{"key":"11401_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3174\/ajnr.A6685","volume":"41","author":"N Soni","year":"2020","unstructured":"Soni N, Ora M, Mohindra N et al (2020) Diagnostic performance of PET and perfusion-weighted imaging in differentiating tumor recurrence or progression from radiation necrosis in posttreatment gliomas: a review of literature. AJNR Am J Neuroradiol 41:1550\u20131557. https:\/\/doi.org\/10.3174\/ajnr.A6685","journal-title":"AJNR Am J Neuroradiol"},{"key":"11401_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5152\/dir.2019.19321","volume":"25","author":"B Ko\u00e7ak","year":"2019","unstructured":"Ko\u00e7ak B, Durmaz E\u015e, Ate\u015f E, K\u0131l\u0131\u00e7kesmez \u00d6 (2019) Radiomics with artificial intelligence: a practical guide for beginners. Diagn Interv Radiol 25:485\u2013495. https:\/\/doi.org\/10.5152\/dir.2019.19321","journal-title":"Diagn Interv Radiol"},{"key":"11401_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","volume":"11","author":"JE van Timmeren","year":"2020","unstructured":"van Timmeren JE, Cester D, Tanadini-Lang S et al (2020) Radiomics in medical imaging-\u201chow-to\u201d guide and critical reflection. Insights Imaging 11:91. https:\/\/doi.org\/10.1186\/s13244-020-00887-2","journal-title":"Insights Imaging"},{"key":"11401_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563\u2013577. https:\/\/doi.org\/10.1148\/radiol.2015151169","journal-title":"Radiology"},{"key":"11401_CR22","doi-asserted-by":"publisher","unstructured":"Kocak B, Keles A, Kose F, Sendur A (2024) Quality of radiomics research: comprehensive analysis of 1574 unique publications from 89 reviews. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-024-11057-z","DOI":"10.1007\/s00330-024-11057-z"},{"key":"11401_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749\u2013762. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141","journal-title":"Nat Rev Clin Oncol"},{"key":"11401_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13244-023-01572-w","volume":"15","author":"B Kocak","year":"2024","unstructured":"Kocak B, Akinci D\u2019Antonoli T, Mercaldo N et al (2024) Methodological radiomics score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII. Insights Imaging 15:8. https:\/\/doi.org\/10.1186\/s13244-023-01572-w","journal-title":"Insights Imaging"},{"key":"11401_CR25","doi-asserted-by":"publisher","unstructured":"Ko\u00e7ak B, Akinci D\u2019Antonoli T, Cuocolo R (2024) Exploring radiomics research quality scoring tools: a comparative analysis of METRICS and RQS. Diagn Interv Radiol Ank Turk. https:\/\/doi.org\/10.4274\/dir.2024.242793","DOI":"10.4274\/dir.2024.242793"},{"key":"11401_CR26","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s11606-018-4425-7","volume":"33","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H, Murad MH et al (2018) Empirical comparison of publication bias tests in meta-analysis. J Gen Intern Med 33:1260\u20131267. https:\/\/doi.org\/10.1007\/s11606-018-4425-7","journal-title":"J Gen Intern Med"},{"key":"11401_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420\u2013428. https:\/\/doi.org\/10.1037\/0033-2909.86.2.420","journal-title":"Psychol Bull"},{"key":"11401_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"11401_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11060-022-04080-x","volume":"159","author":"M Moassefi","year":"2022","unstructured":"Moassefi M, Faghani S, Conte GM et al (2022) A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients. J Neurooncol 159:447\u2013455. https:\/\/doi.org\/10.1007\/s11060-022-04080-x","journal-title":"J Neurooncol"},{"key":"11401_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdad016","volume":"5","author":"R Leone","year":"2023","unstructured":"Leone R, Meredig H, Foltyn-Dumitru M et al (2023) Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma. Neurooncol Adv 5:vdad016. https:\/\/doi.org\/10.1093\/noajnl\/vdad016","journal-title":"Neurooncol Adv"},{"key":"11401_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdz019","volume":"1","author":"A Bani-Sadr","year":"2019","unstructured":"Bani-Sadr A, Eker OF, Berner L-P et al (2019) Conventional MRI radiomics in patients with suspected early- or pseudo-progression. Neurooncol Adv 1:vdz019. https:\/\/doi.org\/10.1093\/noajnl\/vdz019","journal-title":"Neurooncol Adv"},{"key":"11401_CR32","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/mp.14003","volume":"47","author":"M Li","year":"2020","unstructured":"Li M, Tang H, Chan MD et al (2020) DC-AL GAN: pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet. Med Phys 47:1139\u20131150. https:\/\/doi.org\/10.1002\/mp.14003","journal-title":"Med Phys"},{"key":"11401_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jocn.2019.10.003","volume":"70","author":"S Bacchi","year":"2019","unstructured":"Bacchi S, Zerner T, Dongas J et al (2019) Deep learning in the detection of high-grade glioma recurrence using multiple MRI sequences: a pilot study. J Clin Neurosci 70:11\u201313. https:\/\/doi.org\/10.1016\/j.jocn.2019.10.003","journal-title":"J Clin Neurosci"},{"key":"11401_CR34","doi-asserted-by":"publisher","first-page":"e19805","DOI":"10.2196\/19805","volume":"8","author":"Y Gao","year":"2020","unstructured":"Gao Y, Xiao X, Han B et al (2020) Deep learning methodology for differentiating glioma recurrence from radiation necrosis using multimodal magnetic resonance imaging: algorithm development and validation. JMIR Med Inform 8:e19805. https:\/\/doi.org\/10.2196\/19805","journal-title":"JMIR Med Inform"},{"key":"11401_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-020-00545-5","volume":"21","author":"Y-Z Sun","year":"2021","unstructured":"Sun Y-Z, Yan L-F, Han Y et al (2021) Differentiation of pseudoprogression from true progression in glioblastoma patients after standard treatment: a machine learning strategy combined with radiomics features from T1-weighted contrast-enhanced imaging. BMC Med Imaging 21:17. https:\/\/doi.org\/10.1186\/s12880-020-00545-5","journal-title":"BMC Med Imaging"},{"key":"11401_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2893043","volume":"2019","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Cao J, Zhang J et al (2019) Differentiation of recurrence from radiation necrosis in gliomas based on the radiomics of combinational features and multimodality MRI images. Comput Math Methods Med 2019:1\u201312. https:\/\/doi.org\/10.1155\/2019\/2893043","journal-title":"Comput Math Methods Med"},{"key":"11401_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82467-y","volume":"11","author":"YW Park","year":"2021","unstructured":"Park YW, Choi D, Park JE et al (2021) Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation. Sci Rep 11:2913. https:\/\/doi.org\/10.1038\/s41598-021-82467-y","journal-title":"Sci Rep"},{"key":"11401_CR38","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.2147\/CMAR.S244262","volume":"12","author":"X-Y Gao","year":"2020","unstructured":"Gao X-Y, Wang Y-D, Wu S-M et al (2020) Differentiation of treatment-related effects from glioma recurrence using machine learning classifiers based upon pre-and post-contrast T1WI and T2 FLAIR subtraction features: a two-center study. Cancer Manag Res 12:3191\u20133201. https:\/\/doi.org\/10.2147\/CMAR.S244262","journal-title":"Cancer Manag Res"},{"key":"11401_CR39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.clinimag.2015.04.003","volume":"39","author":"X Chen","year":"2015","unstructured":"Chen X, Wei X, Zhang Z et al (2015) Differentiation of true-progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide by GLCM texture analysis of conventional MRI. Clin Imaging 39:775\u2013780. https:\/\/doi.org\/10.1016\/j.clinimag.2015.04.003","journal-title":"Clin Imaging"},{"key":"11401_CR40","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1007\/s00330-022-09365-3","volume":"33","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wu Y, Wang Y et al (2022) Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence. Eur Radiol 33:3332\u20133342. https:\/\/doi.org\/10.1007\/s00330-022-09365-3","journal-title":"Eur Radiol"},{"key":"11401_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77389-0","volume":"10","author":"J Lee","year":"2020","unstructured":"Lee J, Wang N, Turk S et al (2020) Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data through deep learning. Sci Rep 10:20331. https:\/\/doi.org\/10.1038\/s41598-020-77389-0","journal-title":"Sci Rep"},{"key":"11401_CR42","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.3390\/cancers12123835","volume":"12","author":"P Lohmann","year":"2020","unstructured":"Lohmann P, Elahmadawy MA, Gutsche R et al (2020) FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation. Cancers (Basel) 12:3835. https:\/\/doi.org\/10.3390\/cancers12123835","journal-title":"Cancers"},{"key":"11401_CR43","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/cncr.32790","volume":"126","author":"H Akbari","year":"2020","unstructured":"Akbari H, Rathore S, Bakas S et al (2020) Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma. Cancer 126:2625\u20132636. https:\/\/doi.org\/10.1002\/cncr.32790","journal-title":"Cancer"},{"key":"11401_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11060-022-04088-3","volume":"159","author":"A Hagiwara","year":"2022","unstructured":"Hagiwara A, Schlossman J, Shabani S et al (2022) Incidence, molecular characteristics, and imaging features of \u201cclinically-defined pseudoprogression\u201d in newly diagnosed glioblastoma treated with chemoradiation. J Neurooncol 159:509\u2013518. https:\/\/doi.org\/10.1007\/s11060-022-04088-3","journal-title":"J Neurooncol"},{"key":"11401_CR45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/neuonc\/noy133","volume":"21","author":"JY Kim","year":"2019","unstructured":"Kim JY, Park JE, Jo Y et al (2019) Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients. Neuro Oncol 21:404\u2013414. https:\/\/doi.org\/10.1093\/neuonc\/noy133","journal-title":"Neuro Oncol"},{"key":"11401_CR46","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00259-019-04604-0","volume":"47","author":"K Wang","year":"2020","unstructured":"Wang K, Qiao Z, Zhao X et al (2020) Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model. Eur J Nucl Med Mol Imaging 47:1400\u20131411. https:\/\/doi.org\/10.1007\/s00259-019-04604-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11401_CR47","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00234-021-02719-6","volume":"63","author":"L Siakallis","year":"2021","unstructured":"Siakallis L, Sudre CH, Mulholland P et al (2021) Longitudinal structural and perfusion MRI enhanced by machine learning outperforms standalone modalities and radiological expertise in high-grade glioma surveillance. Neuroradiology 63:2047\u20132056. https:\/\/doi.org\/10.1007\/s00234-021-02719-6","journal-title":"Neuroradiology"},{"key":"11401_CR48","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3390\/cancers12092706","volume":"12","author":"B-S Jang","year":"2020","unstructured":"Jang B-S, Park AJ, Jeon SH et al (2020) Machine learning model to predict pseudoprogression versus progression in glioblastoma using MRI: a multi-institutional study (KROG 18-07). Cancers (Basel) 12:2706. https:\/\/doi.org\/10.3390\/cancers12092706","journal-title":"Cancers"},{"key":"11401_CR49","doi-asserted-by":"publisher","first-page":"628.e17","DOI":"10.1016\/j.crad.2021.03.019","volume":"76","author":"M Patel","year":"2021","unstructured":"Patel M, Zhan J, Natarajan K et al (2021) Machine learning-based radiomic evaluation of treatment response prediction in glioblastoma. Clin Radiol 76:628.e17\u2013628.e27. https:\/\/doi.org\/10.1016\/j.crad.2021.03.019","journal-title":"Clin Radiol"},{"key":"11401_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11007-0","volume":"10","author":"N Elshafeey","year":"2019","unstructured":"Elshafeey N, Kotrotsou A, Hassan A et al (2019) Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat Commun 10:3170. https:\/\/doi.org\/10.1038\/s41467-019-11007-0","journal-title":"Nat Commun"},{"key":"11401_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31007-2","volume":"8","author":"B-S Jang","year":"2018","unstructured":"Jang B-S, Jeon SH, Kim IH, Kim IA (2018) Prediction of pseudoprogression versus progression using machine learning algorithm in glioblastoma. Sci Rep 8:12516. https:\/\/doi.org\/10.1038\/s41598-018-31007-2","journal-title":"Sci Rep"},{"key":"11401_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.compbiomed.2016.03.027","volume":"73","author":"J Zhang","year":"2016","unstructured":"Zhang J, Yu H, Qian X et al (2016) Pseudo progression identification of glioblastoma with dictionary learning. Comput Biol Med 73:94\u2013101. https:\/\/doi.org\/10.1016\/j.compbiomed.2016.03.027","journal-title":"Comput Biol Med"},{"key":"11401_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.100916","volume":"8","author":"AS McKenney","year":"2023","unstructured":"McKenney AS, Weg E, Bale TA et al (2023) Radiomic analysis to predict histopathologically confirmed pseudoprogression in glioblastoma patients. Adv Radiat Oncol 8:100916. https:\/\/doi.org\/10.1016\/j.adro.2022.100916","journal-title":"Adv Radiat Oncol"},{"key":"11401_CR54","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/biomedicines9121924","volume":"9","author":"S Ahrari","year":"2021","unstructured":"Ahrari S, Zaragori T, Rozenblum L et al (2021) Relevance of dynamic 18F-DOPA PET radiomics for differentiation of high-grade glioma progression from treatment-related changes. Biomedicines 9:1924. https:\/\/doi.org\/10.3390\/biomedicines9121924","journal-title":"Biomedicines"},{"key":"11401_CR55","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.18632\/oncotarget.14166","volume":"8","author":"S Kebir","year":"2017","unstructured":"Kebir S, Khurshid Z, Gaertner FC et al (2017) Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma. Oncotarget 8:8294\u20138304. https:\/\/doi.org\/10.18632\/oncotarget.14166","journal-title":"Oncotarget"},{"key":"11401_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.110830","volume":"163","author":"B Kocak","year":"2023","unstructured":"Kocak B, Bulut E, Bayrak ON et al (2023) Negative results in radiomics research (NEVER): a meta-research study of publication bias in leading radiology journals. Eur J Radiol 163:110830. https:\/\/doi.org\/10.1016\/j.ejrad.2023.110830","journal-title":"Eur J Radiol"},{"key":"11401_CR57","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/1754-9485.13436","volume":"66","author":"A Bhandari","year":"2022","unstructured":"Bhandari A, Marwah R, Smith J et al (2022) Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: a systematic review and meta-analysis. J Med Imaging Radiat Oncol 66:781\u2013797. https:\/\/doi.org\/10.1111\/1754-9485.13436","journal-title":"J Med Imaging Radiat Oncol"},{"key":"11401_CR58","doi-asserted-by":"publisher","unstructured":"Booth TC, Grzeda M, Chelliah A et al (2022) Imaging biomarkers of glioblastoma treatment response: a systematic review and meta-analysis of recent machine learning studies. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.799662","DOI":"10.3389\/fonc.2022.799662"},{"key":"11401_CR59","doi-asserted-by":"publisher","first-page":"e23766","DOI":"10.1097\/MD.0000000000023766","volume":"99","author":"L Wang","year":"2020","unstructured":"Wang L, Wei L, Wang J et al (2020) Evaluation of perfusion MRI value for tumor progression assessment after glioma radiotherapy: a systematic review and meta-analysis. Medicine (Baltimore) 99:e23766. https:\/\/doi.org\/10.1097\/MD.0000000000023766","journal-title":"Medicine"},{"key":"11401_CR60","doi-asserted-by":"publisher","unstructured":"Russo L, Bottazzi S, Kocak B et al (2024) Evaluating the quality of radiomics-based studies for endometrial cancer using RQS and METRICS tools. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-024-10947-6","DOI":"10.1007\/s00330-024-10947-6"},{"key":"11401_CR61","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/diagnostics14080832","volume":"14","author":"G Aghakhanyan","year":"2024","unstructured":"Aghakhanyan G, Filidei T, Febi M et al (2024) Advancing pediatric sarcomas through radiomics: a systematic review and prospective assessment using radiomics quality score (RQS) and methodological radiomics score (METRICS). Diagnostics (Basel) 14:832. https:\/\/doi.org\/10.3390\/diagnostics14080832","journal-title":"Diagnostics"},{"key":"11401_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111510","volume":"176","author":"R Castellana","year":"2024","unstructured":"Castellana R, Fanni SC, Roncella C et al (2024) Radiomics and deep learning models for CT pre-operative lymph node staging in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Eur J Radiol 176:111510. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111510","journal-title":"Eur J Radiol"},{"key":"11401_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111577","volume":"177","author":"P-F Jia","year":"2024","unstructured":"Jia P-F, Li Y-R, Wang L-Y et al (2024) Radiomics in esophagogastric junction cancer: a scoping review of current status and advances. Eur J Radiol 177:111577. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111577","journal-title":"Eur J Radiol"},{"key":"11401_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2024.110225","volume":"113","author":"P Jannatdoust","year":"2024","unstructured":"Jannatdoust P, Valizadeh P, Pahlevan-Fallahy M-T et al (2024) Diagnostic accuracy of CT-based radiomics and deep learning for predicting lymph node metastasis in esophageal cancer. Clin Imaging 113:110225. https:\/\/doi.org\/10.1016\/j.clinimag.2024.110225","journal-title":"Clin Imaging"},{"key":"11401_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmir.2024.101746","volume":"55","author":"R Shahidi","year":"2024","unstructured":"Shahidi R, Hassannejad E, Baradaran M et al (2024) Diagnostic performance of radiomics in prediction of Ki-67 index status in non-small cell lung cancer: a systematic review and meta-analysis. J Med Imaging Radiat Sci 55:101746. https:\/\/doi.org\/10.1016\/j.jmir.2024.101746","journal-title":"J Med Imaging Radiat Sci"},{"key":"11401_CR66","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00198-024-07136-y","volume":"35","author":"L Deng","year":"2024","unstructured":"Deng L, Shuai P, Liu Y et al (2024) Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis. Osteoporos Int 35:1693\u20131707. https:\/\/doi.org\/10.1007\/s00198-024-07136-y","journal-title":"Osteoporos Int"},{"key":"11401_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111652","volume":"178","author":"Z HajiEsmailPoor","year":"2024","unstructured":"HajiEsmailPoor Z, Kargar Z, Baradaran M et al (2024) Prognostic value of CT scan-based radiomics in intracerebral hemorrhage patients: a systematic review and meta-analysis. Eur J Radiol 178:111652. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111652","journal-title":"Eur J Radiol"},{"key":"11401_CR68","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s11547-024-01840-9","volume":"129","author":"K Deng","year":"2024","unstructured":"Deng K, Chen T, Leng Z et al (2024) Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. Radiol Med 129:1099\u20131117. https:\/\/doi.org\/10.1007\/s11547-024-01840-9","journal-title":"Radiol Med"},{"key":"11401_CR69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13244-023-01415-8","volume":"14","author":"B Kocak","year":"2023","unstructured":"Kocak B, Baessler B, Bakas S et al (2023) Checklist for evaluation of radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII. Insights Imaging 14:75. https:\/\/doi.org\/10.1186\/s13244-023-01415-8","journal-title":"Insights Imaging"},{"key":"11401_CR70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s41747-024-00471-z","volume":"8","author":"B Kocak","year":"2024","unstructured":"Kocak B, Borgheresi A, Ponsiglione A et al (2024) Explanation and elaboration with examples for CLEAR (CLEAR-E3): an EuSoMII Radiomics Auditing Group Initiative. Eur Radiol Exp 8:72. https:\/\/doi.org\/10.1186\/s41747-024-00471-z","journal-title":"Eur Radiol Exp"},{"key":"11401_CR71","doi-asserted-by":"publisher","unstructured":"Tejani AS, Klontzas ME, Gatti AA et al (2024) Checklist for artificial intelligence in medical imaging (CLAIM): 2024 update. Radiol Artif Intell. https:\/\/doi.org\/10.1148\/ryai.240300","DOI":"10.1148\/ryai.240300"},{"key":"11401_CR72","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1007\/s00330-023-10217-x","volume":"34","author":"T Akinci D\u2019Antonoli","year":"2024","unstructured":"Akinci D\u2019Antonoli T, Cavallo AU, Vernuccio F et al (2024) Reproducibility of radiomics quality score: an intra- and inter-rater reliability study. Eur Radiol 34:2791\u20132804. https:\/\/doi.org\/10.1007\/s00330-023-10217-x","journal-title":"Eur Radiol"},{"key":"11401_CR73","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1007\/s00330-023-10487-5","volume":"34","author":"B Kocak","year":"2024","unstructured":"Kocak B, Akinci D\u2019Antonoli T, Ates Kus E et al (2024) Self-reported checklists and quality scoring tools in radiomics: a meta-research. Eur Radiol 34:5028\u20135040. https:\/\/doi.org\/10.1007\/s00330-023-10487-5","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11401-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:16:39Z","timestamp":1751544999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11401-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":73,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["11401"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11401-x","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"13 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Burak Kocak, MD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"B.K. is on the editorial board of\n                      European Radiology\n                      (section editor: Imaging Informatics and Artificial Intelligence). He has not taken part in the review or selection process of this article. He took part in the development of METRICS\u00a0and CLEAR. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because it is a systematic review.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because it is a systematic review.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}